The intracellular parasite Listeria monocytogenes is able to induce its internalization by cultured mammalian cells that are not normally phagocytic. This process requires the expression of the chromosomal locus inlAB. We studied the virulence of an inlAB mutant and of its parent in rnurine listeriosis. Irrespective of the route of inoculation, the inlAB mutant was severely attenuated for growth in the liver. The livers of mice inoculated with the inlAB mutant displayed much smaller infectious foci than the parent as early as 24 h after infection. Electron microscopy showed that these foci consisted of a few inflammatory cells, with few bacteria; bacteria were rarely found within hepatocytes. In contrast, foci in livers of mice inoculated with the parent consisted of islets of heavily infected hepatocytes that were infiltrated by numerous neutrophils; bacteria seemed intact within hepatocytes and damaged within neutrophils. A direct role of inlAB for the entry of L. monocytogenes into hepatocytes was confirmed in a cell infection system using the murine embryonic hepatocyte cell line TIB73. The inlAB mutant was ~20-fold less invasive than its parent and recovered a full invasive phenotype when inlAB was provided in trans. The "invasion locus" inlAB contributes to protect L. monocytogenes from the host's innate defense mechanisms by promoting its entry into hepatocytes.
V
arious bacterial pathogens are able to trigger their uptake by cultured mammalian cells that are not normally phagocytic, such as epithelial cells or fibroblasts (1). Much work in recent years has addressed the bacterial factors involved in the process of entry. Loci required for invasion of nonprofessional phagocytic cells have thus been identified in the genomes of Gram-negative and Grampositive bacteria, including Yersinia (2, 3), Salmonella (4, 5) , Shigella (6) , and Listeria (7) . It is a seductive idea that these "invasion loci" may contribute to virulence by giving the bacteria access to an intracellular niche protected from the host's phagocytes (8) . However, to date, there is no experimental evidence for this hypothesis.
Listeria monocytogenes is a particularly attractive model for investigating the role of invasion loci in vivo. This ubiquitous Gram-positive bacterium can infect both macrophages (9) and nonprofessional phagocytes, including epithelial cells, fibroblastic cells, and hepatocytes (10) (11) (12) (13) (14) . It is a welladapted intracellular pathogen that can grow within the cytoplasm of its host cell (11, 15) and takes advantage of the host cell machinery to pass directly into the cytoplasm of neighboring host cells (16, 17) . Murine listeriosis is a welldocumented model of infection and has been widely used for studying cellular immunity.
By analysis of noninvasive transposon insertion mutants, we have recently identified a chromosomal locus that is absolutely required for the entry of L. monocytogenes into cultured epithelial cells (7) . This locus is an operon and is controlled by the activator PrfA (18) , as are the virulencerelated genes of the hly region (19, 20) . It is composed of two genes, inlA and inlB. The inlA gene is necessary and sufficient to render the normally noninvasive species Listeria innocua invasive for cultured epithelial cells. It encodes an 800-amino acid protein, internalin, which is structurally analogous to certain surface proteins in Gram-positive organisms (7, 21) . The inlB gene is very similar to inlA and encodes a 630-amino acid protein.
After entering the host through the gastrointestinal tract, L. monocytogenes spreads via the lymph and blood to distant tissues. In murine infection, it accumulates predominantly in the liver, where it replicates until the host mobilizes a protective cellular immune response (9, 22, 23) . Until recently, it was generally believed that the growth of L. monocytogenes in the liver was due to its ability to grow within the resident macrophages, the Kiipffer cells (9) . However, several recent works have clearly shown that L. monocytogenes replicates in hepatocytes rather than in Kiipffer cells (13, (24) (25) (26) . In mice infected intravenously with a sublethal dose, there is an ~200-fold increase in the number of hepatocyte-associated Listeria during the first 3 d, and a <twofold increase in the number of Kiipffer cell-associated Listeria (26) . Hepatocyte invasion is now considered as a key event in liver infection and is being analyzed in in vitro cellular assay systems (14) .
We studied the role of intAB in routine listeriosis and provide evidence that this locus allows L. monocytogenes to circumvent the host's innate defense mechanisms by promoting its entry into hepatocytes.
Materials and Methods
Bacterial Strains and Growth Conditions. L. monocytogenes strains EGD-SmR and BUG8 were used throughout the study. EGDSmlL is a streptomycin-resistant derivative of strain EGD (27) . BUG8 is a transposon Tni545 mutant from EGD-SmP,, which is ,'-,50-fold less invasive than its parent for cultured epithelial cells (7) . The transposon insertion in BUG8, 417 bp upstream of the start codon of inlA (21) , prevents the transcription of inlA and inlB (7) . The BUG8-derivative strains JLG101, JLG102, and JLG103 were obtained in this study. JLG102 and JLG103 harbor the pAT28 derivatives pGM4 and pGM2, respectively; JLG101 harbors the vector pAT28. Plasmids pGM2 and pGM4 have been described elsewhere; they carry inlAB and inlA, respectively (7). Plasmid pAT28 and derivatives were introduced into Escherichia coil strain HB101 (pRK212.1) by transformation and transferred from E. coli to L. monocytogenes BUG8 by conjugation (7) . Transconjugants were selected on tryptic soy agar containing spectinomycin (60 mg/liter) and nalidixic acid (50 rag/liter) (Sigma Chemical Co., St. Louis, MO). JLG101, JLG102, and JLG103 were used for in vitro but not for in vivo experiments, owing to the instability of the vector pAT28 and derivatives in these strains, g innocua BUG263, BUG261, and BUG531 derive from the strain CLIP11254 and harbor the plasmids pAT28, pGM2, and pGM4, respectively (7, 18) . Listeria strains were grown in tryptic soy broth (Diagnostics Pasteur, Marnes-la-Coquette, France) at 37~ without shaking. Spectinomycin (60 rag/liter) was added to cultures of strains harboring plasmid pAT28 and derivatives.
Analysis of Virulence in Mice. Specific pathogen-free female Swiss mice (Charles Rivers, Saint-Aubin-l~s-Elbeuf, France) were used when they were 6-8 wk old. The challenge inoculum was prepared from 18-h cultures in tryptic soy broth, containing antibiotics as appropriate. Bacteria were pelleted by centrifugation, washed once, and diluted appropriately in 0.15 M NaC1. Mice were infected by direct intragastric inoculation with 109 bacteria (in 0.25 ml) by means of a feeding needle for oral challenge, and by intravenous injection of either 5 • 10 s or 3 • 10 ~ bacteria (in 0.5 ml) for intravenous challenge. Bacterial growth in liver and spleen was determined by killing groups of five mice at various intervals after infection. Mice were killed by cervical dislocation, in accordance with the policies of the animal welfare committee of the Facult6 Necker-Enfants Malades. The liver and spleen were aseptically removed and ground. Samples (0.1 ml) of serial dilutions of whole-organ homogenates were surface plated on tryptic soy agar (Diagnostics Pasteur). Bacterial counts in BUG8-infected mice were determined in parallel on tryptic soy agar containing or not containing kanamycin (25 mg/liter) to assess the presence of Tn1545 in bacteria. Colonies were counted after 24 h of incubation at 37~ and the results were expressed as the mean log10 bacteria per organ. The minimum detection limit was 2 logm bacteria per organ. The intravenous LDs0 was estimated by the probit method. Groups of eight mice were challenged intravenously with various doses of bacteria, and mortality was observed for 3 wk.
Histology. Mice were challenged intravenously with a dose of 108 bacteria (in 0.5 ml) and killed by cervical dislocation at intervals of up to 1 wk. Small pieces of liver were removed and processed for Gram staining, immunolabeling, or electron microscopy. Samples to be Gram stained were fixed in 10% formalin and embedded in paraffin; 2-3-1xm sections were cut and stained using the Gram-Weigert procedure. Samples to be imnmnolabeled were embedded in OCT compound (Miles Scientific, Naperville, IL) and frozen in liquid-cooled isopentane (Sigma Chemical Co.). Cryostat sections 5-7-txm thick were cut, mounted onto glass slides, and fixed in acetone. Sections were first incubated with a rabbit anti-L, monocytogenes serum (1:100 dilution) for 1 h, and then with peroxidase-conjugated goat antirabbit IgG (1:100 dilution) (Sigma Chemical Co. Gentamicin Suwival Assay. Bacterial inoculum was prepared as described for virulence testing. Cell monolayers grown in 35-mm tissue culture plates were infected for 1 h at 37~ at a multiplicity of infection of ~100 bacteria per cell. After two washings, the cells were reincubated in fresh DMEM containing gentamicin (Sigma Chemical Co.) at concentrations of either 5, 10, or 25 rag/liter. At intervals, they were washed twice and lysed by adding cold water. Viable bacteria released from the cells were titered on agar plates.
lmmunofluorescence Microscopy. Cell monolayers grown on glass coverslips were infected as described above. At intervals during the incubation period in the presence of gentamicin, the cells were washed twice with PBS, fixed with 3% paraformaldehyde (wt/vol in PBS) for 30 rain at room temperature, and permeabilized for 5 rain in 0.1% Triton X-100 (Sigma Chemical Co.) in PBS. Cells were then washed three times with PBS and processed for immunolabeling and actin staining. For immunolabeling, cells were incubated sequentially with appropriate dilutions of a polyclonal rabbit anti-L, monocytogenes EGD antibody and of a FITC goat anti-rabbit antibody (Jackson ImmunoP, esearch Laboratories Inc., Bio/Can Scientific, Mississauga, Canada) in 1% BSA-PBS; incubations were carried out for 30 rain at room temperature. Rhodamine-phalloidin (Molecular Probes, Inc., Eugene, OR) was used for F-actin staining_ Coverslips were mounted on slides and examined by fluorescence microscopy using a microscope (Axioskop; Carl Zeiss, Inc., Thornwood, NY).
Plaque Assay. Plaque formation by L. monocytogenes was assayed in the mouse L2 fibroblast cell line, using a protocol modi-fled from Sun et al. (28) . Briefly, confluent L2 monolayers obtained in 6-weU tissue culture dishes (Falcon Labware) were infected with 1-20 p~l of a bacterial inoculum prepared as described above. After 1 h of incubation at 37~ the monolayers were washed three times and overlaid with culture medium containing 0.75% agarose and 10 p~g of gentamicin per milliliter. After 3 d, plaques were visualized by the addition of 0.1% neutral red (Sigma Chemical Co.).
Results

Virulence of the inlAB Mutant in Mice.
The inlAB mutant BUG8 and its parent EGD-SmR were first studied in mice infected by the oral route. Mice were challenged by intragastric inoculation of 109 bacteria, and bacterial spreading to the liver and spleen was followed as indicative of intestinal translocation (Fig. 1 ). Both strains were isolated from these organs from day 2, thus indicating that the inlAB mutant retained the ability to invade the host through the gut. The bacterial growth curves, however, were similar for the two strains in the spleen and dissimilar in the liver. The bacterial counts in the spleen were slightly lower for BUG8 than for EGD-SmR at all time points, but the growth curves were parallel. This was not the case in the liver: There was a 10-fold difference in the bacterial [,.. counts of the two strains as early as day 2. BUG8 failed to grow and was totally eliminated from the liver by day 4, whereas EGD-SmR proliferated. Oral LDs0 experiments were not performed because mice infected orally with EGD-SmR survive challenges as high as 10 ~~ bacteria (Galliard, J.-L., unpublished data).
LIVER ~ SPLEEN
Thus, BUG8 appeared to be cleared more readily from liver than EGD-SmR. This was confirmed by infecting mice by the intravenous route. Mice were challenged intravenously with 5 • 10 s or 3 • 10 6 bacteria, and bacterial growth was followed in liver and spleen (Fig. 1) . With the dose of 3 • 10 6 bacteria, the bacterial growth curves in the spleen were comparable for the two strains until day 3, when the first EGD-SmR-infected mice began to die. In contrast, the growth curves in the liver were quite different. After a fourfold reduction of the inoculum during the first 6 h of infection, EGD-SmR multiplied rapidly in the liver during the first 2 d of infection (90-fold increase in bacterial counts from 6 to 48 h). Mice began to die on day 3. Of the 10 mice kept to determine bacterial counts on days 8 and 10, three had died by day 4 and two more by day 6. For BUG8, after the initial decrease in bacterial counts, a low rate of bacterial growth was observed until day 2 (1.5-fold increase in bacterial counts from 6 to 48 h). Bacteria were completely eliminated from the liver within 8 d. None of the BUG8-infected animals died.
The dose of 5 X 105 bacteria did not result in the death of any mouse infected with EGD-SmR or BUG8. This allowed us to continue the bacterial growth curves over 8 d for both strains. Again, it was found that EGD-SmR and BUG8 behaved similarly in the spleen and dissimilarly in the liver during the first days of infection. In the latter organ, the number of EGD-SmR bacteria increased 20-fold and the number of BUG8 bacteria only 1.6-fold from 6 to 48 h after the challenge.
The intravenous LDs0s were determined and were 107.55 for BUG8 and 106.7{) for EGD-SmR. This difference is consistent with the mortality rates observed during the analysis of bacterial growth in organs after the highest challenge.
Role of inlAB for Hepatocyte Invasion In Vivo.
Liver sections from mice inoculated intravenously with the inlAB mutant BUG8 or EGD-SmR were examined microscopically. A high inoculum (108 bacteria/mouse) was used to facilitate visualization of bacteria by optical and electron microscopy. The histopathology of livers from mice infected by EGD-SmR and BUG8 was different. The livers of mice inoculated with EGD-SmR were studded with large infectious foci as early as 24 h (Fig. 2, a and c) . Consistent with recent studies of other invasive L. monocytogenes strains (13, 24) , the foci were constituted of clusters of heavily infected hepatocytes and of inflammatory cells recruited locally, predominantly neutrophils (Fig. 3 a) . Electron microscopy visualized bacteria free within the cytoplasm of hepatocytes, sometimes dividing, whereas in neutrophils the bacteria were confined in all cases within phagosomes and were often being destroyed (Fig. 3 b) . After 48 h of infection, nearly all mice inoculated with EGD-SmR were dead. Very large infectious loci were found in liver sections of surviving animals (Fig. 4 a) . The centers of the lesions were necrotic. Bacteria were abundant in peripheral hepatocytes, suggesting that they had multiplied unrestrictedly while propagating radially from hepatocyte to hepatocyte. N o animal survived after 72 h of infection.
The livers of mice infected with the same dose of BUG8 gave a very different aspect. By 24 h, the infectious loci were scarce and much smaller than those for E G D -S m R (Fig. 2, b and d) . A typical lesion was populated by a few inflammatory cells and contained no more than 15-25 bacteria. The infectious loci were analyzed by electron microscopy. They were small and rare, and thus their detection required many more grids than for E G D -S m R . The foci contained a few inflammatory cells, which had moved out of the sinusoids and had accumulated locally (Fig. 3 c) . Neutrophils and mononuclear cells were present in equal proportion, in close physical contact with hepatocytes. Most bacteria were seen in inflammatory cells. In mononuclear cells but not in neutrophils, some appeared free within the cytoplasm and surrounded by a dense microfibrillar material, presumably actin. Thus, some of the bacteria within mononuclear cells appeared to be capable of intracellular movements in the in vivo setting. A few bacteria were found inside hepatocytes adjacent to infected mononuclear cells, suggesting that the hepatocytes might have been infected through bacterial spreading from mononuclear cell to hepatocyte. The rare bacteria inside hepatocytes replicated freely within the cytoplasm, sometimes appearing as a dividing organism coated with actin. Some ultrathin liver sections from BUG8-infected mice displayed a different pattern (Fig. 3 d) : Rare bacteria were confined in a Ktipffer cell, without any adjacent inflammatory cell; the bacteria were located within vacuoles, and most appeared to be in the process of destruction.
All mice were alive after 48 h of infection with BUG8. The infectious foci in liver had increased in size by local recruitment of inflammatory cells but remained much smaller than those observed with E G D -S m R after the same time period (Fig. 4 b) . Bacteria were detected inside inflammatory cells and hepatocytes. Infection of hepatocytes remained restricted to a very few individual cells, and each hepatocyte contained a small n u m b e r of bacteria. Only a small proportion of BUG8-inoculated mice died between day 3 and day 7, confirming the weak virulence of BUG8. Microscopic examination of liver sections from the surviving mice showed a rapid disappearance of bacteria, with a complete healing of loci by day 7 (not shown).
Role of inlAB in Bacterial Entry into Hepatocytic Cells In Vitro.
The histological data suggested that inlAB promotes the early entry of L. monocytogenes into hepatocytes and that this is a prerequisite for bacterial growth and dissemination in the hepatic parenchyma. To investigate the role of inlAB for the invasion of murine hepatocytes, we infected the murine hepatocyte cell line TIB73 with E G D -S m R and BUG8, complemented or not in trans with inlA or inlAB.
Bacterial entry was assessed using a gentamicin survival assay with an antibiotic concentration of 5 mg/liter. It was found that B U G 8 was ,'-~20-fold less invasive than E G D -S m R (Table 1) . We checked that presumably intracellular B U G 8 bacteria were not invasive revertants. 20 independent colonies were randomly selected and assayed for entry.
In each case, the bacteria exhibited the same phenotype as BUG8. The introduction of a plasmid carrying inlAB into B U G 8 restored completely the ability of this mutant to invade TIB73 cells, whereas the introduction of the vector without insert or carrying inlA had no effect on entry (Table 1). Overall, the levels found with E G D -S m R , BUG8, and its derivatives in the TIB73 model were very low compared with other cell systems (e.g., the Caco-2 cell line) (7) . However, the numbers of bacteria recovered after gentamicin treatment with these strains were much higher than those found with the k innocua strains (Table 1 ) and thus could not be regarded as background levels due to the presence of surviving extracellular bacteria. This was consistent with BUG8, suggesting that this mutant was only partially entry defective (see below). Also, in contrast with previous findings in the Caco-2 model (7), neither the expression of inlAB nor that of inlA was sufficient to promote the entry of L. innocua in TIB73 cells.
Infection of TIB73 monolayers with E G D -S m R and B U G 8 was followed for 18 h in the presence ofgentamicin at different concentrations. At given times, cells were washed and either lysed for enumerating viable bacteria or processed for fluorescence microscopy. Similar results were observed for the different concentrations of gentamicin tested (Fig. 5) . B U G 8 entered the cells with a low efficiency, but its intracellular growth rate was comparable to that of E G D -S m R (generation time of ~-'1 h during the first 8 h of infection for both strains). Microscopic examination of monolayers after irmnunolabeling of bacteria and F-actin staining showed that B U G 8 behaved like the parental strain inside cells. After 18 h of infection, the foci of bacterial replication formed by both strains were identical (Fig. 6) ; however, they were 10-20-fold less numerous with BUG8, because of the lower invasive capacity of this strain compared with its parent. The ability of B U G 8 to grow intracellularly and to propagate from cell to cell was also evaluated in a plaque assay using the mouse L2 fibroblast cell line (28) . Consistent with the data obtained in the TIB73 model, plaques formed by B U G 8 were 10-20-fold less numerous than those formed with E G D -S m R , but their morphology was strictly normal (not shown).
Discussion
The aim of this work was to characterize the role of the inlAB locus in infection of a living host by L. monocytogenes. TIB73 monolayers were infected for 1 h at 37~ with 100 bacteria per cell. After washing, the cells were overlaid with f~esh culture medium containing gentamicin (5 rag/liter) and reincubated for 2 h at 37~ The cells were then washed again and lysed, and viable bacteria were titered on agar plates. The results are expressed as the mean number (+ SD) of viable bacteria per well (three determinations).
This was addressed by studying the virulence of an inlAB mutant and of its parent in murine listeriosis. Human listeriosis usually occurs by the intestinal route, after ingestion of Listeria-contaminated food products (29) . InlAB was found to be required for the penetration ofk monocytogenes into an enterocytic cell line (7), and we therefore postulated that this locus was necessary for L. monocytogenes translocation through the gut mucosa. Analysis of oral infections in mice showed that the inlAB mutant remained able to cause a systemic infection after oral challenge, with bacterial spread to hver and spleen. Figure 5 . Growth of EGD-SmR and BUG8 in TIB73 cells. TIB73 monolayers were infected for 1 h at 37~ with 100 bacteria per cell. After washing, the cells were reincubated for 18 h in fresh culture medium containing gentamicin at a concentration of 5 ( 9 10 ([2), and 25 (A) mg/ liter. At intervals, the cells were washed again and lysed, and viable bacteria were titered on agar plates. Data points and error bars represent the mean and SD of the number of bacteria per well (mean of three determinations). BUG8 was "~20-fold less invasive than EGD-SmP, but multiplied intracellularly to the same extent as its parent. (11) , and, in nonconfluent monolayers, the bacteria enter via cells at the periphery of Caco-2 islets (17) . This suggests that L. monocytogenes enters enterocytic cells by the basolateral domain of the cell surface, as demonstrated for Shigella (34) . Thus, L. monocytogenes may be unable to invade enterocytes by their apical pole in the intestine and require M cell transport for translocating from the intestinal lumen.
Although our results demonstrate that inlAB is not essential to L. monocytogenes for crossing the gut mucosa, they do not exclude a role for this locus at the intestinal step of infection. It has been suggested that ShigeUa infection of M cells is followed by basolateral infection ofenterocytes (34) . A similar process could occur during Listeria infection, involving in/AB-dependent mechanisms. Enterocytes may thus be the first site of bacterial rephcation in the host. This view is supported by a previous electron microscopic study in which Listeria given orally to guinea pigs could be seen dividing inside enterocytes of the small intestine within 3 h of inoculation (35) . Furthermore, our results show that the initial counts in hver and spleen of orally challenged mice were substantially lower for the inlAB mutant than for its parent.
Our data provide evidence that the invasion of hepatocytes by L. monocytogenes in mice is promoted by the inlAB locus. First, the inlAB mutant inoculated into mice by the oral and the intravenous routes was severely attenuated for growth in the hver. Bacterial counts increased 1.5-fold for the inlAB mutant and 90-fold for the parental strain from 6 to 48 h after an intravenous challenge of 2 • 106 bacteria (inlAB mutant 0.1 LDs0 ). Second, histological examination of the hvers showed that the inlAB mutant failed to accumulate in hepatocytes. 24 h after an intravenous challenge of 108 inlAB mutant bacteria, the infectious foci were composed of a small number of inflammatory cells, with few visible bacteria; bacteria were rarely found within hepatocytes by electron microscopy. In contrast, after 24 h of infection, the foci in the livers of mice challenged with the parental strain consisted of islets of heavily infected hepatocytes that were infiltrated by numerous inflammatory cells, predominantly neutrophils.
The role of inlAB for the invasion of hepatocytes in vivo was strengthened by the results of in vitro experiments using the murine hepatocyte cell line TIB73. The inlAB mutant was ,'-,20-fold less invasive for TIB73 cells than the parental strain and recovered its invasive capabihty when inlAB was provided in trans. In contrast to the results of a previous study using the colon carcinoma cell line Caco-2 (7), we found that the presence of inlA in trans was not sufficient to restore the invasive capability of the inlAB mutant for TIB73 cells. This is in full agreement with a recent study from Dramsi et al., in which different cell lines were infected with inIA, inlB, and inlAB deletion mutants from strain EGD (36) . These authors have shown that inlB is necessary to the entry of L. monocytogenes into the cell line TIB73 and, to a lesser extent, into the human hepatoma cell line HepG2. Thus, the entry o f L. monocytogenes into hepatocytes appears to require the coordinate expression of inlA and inlB. Moreover, since the expression o f inlAB is not sufficient to promote the entry of L. innocua into cultured hepatocytes (36; this study), other L. monocytogenesspecific genes, possibly belonging to the inl gene family, may also be necessary for the completion of this process.
Some in vitro results may explain the behavior of the inlAB mutant in the liver of mice. First, this strain was only partially entry defective, presumably because L. rnonocytogenes possesses other invasion determinants than inlAB. This might account, at least partially (see below), for the low degree of hepatocyte invasion observed in mice inoculated with the inlAB mutant. Another interesting result arising from in vitro studies was the demonstration that, once inside host cells, the inIAB mutant behaves in the same man-ner as its parent. After 18 h of infection, large plaques containing hundreds of intracellular bacteria were observed with both strains in TIB73 monolayers. Moreover, the inlAB mutant formed normal plaques in mouse L2 fibroblast monolayers, confirming that this strain retained its ability to spread from cell to cell.
Together, these data suggest the existence of two distinct pathways of hepatocyte invasion by L. monocytogenes (Fig.  7) . The first steps of infection are common to both pathways. The bacteria circulating in the liver sinusoids are trapped by Kfipffer cells, where most of them are destroyed rapidly. A variable proportion of bacteria, depending on the inoculum size, is able to escape from the phagolysosomes of K/.ipffer cells and replicate. In the first pathway of hepatocyte invasion (Fig. 7 a) , the bacteria might be released from damaged Kfipffer cells into the extracellular environment and enter hepatocytes by a phagocytic-like process induced by InlAB. It is likely that this pathway is greatly favored by heavy bacterial burdens as it requires the destruction of Kfipffer cells (compare the bacterial growth curves in the livers of mice challenged with 5 • 10 ~ and 3 • 106 EGD-SmR bacteria in Fig. 1) .
Data from some electron micrographs suggest that a second pathway may occur involving the actin-based propagation of the bacteria from Kiipffer cells (or, at later stages, from monocytes recruited locally) to adjacent hepatocytes (Fig. 7 b) . This pathway is probably much less sensitive to the inoculum size and may play a major role at the low doses occurring in natural infections. The expression of actA is essential to the completion of this process but also to the propagation of L. monocytogenes from hepatocyte to hepatocyte. Thus, an actA mutant can enter hepatocytes via the first pathway but cannot disseminate in the liver parenchyma. This explains how an actA mutant (37) is much less virulent than an inlAB mutant, which enters hepatocytes via the second pathway and subsequently is able to spread from hepatocyte to hepatocyte. Although the inlAB mutant behaves normally in terms of cell-to-cell spreading, it gives infectious loci of small size in the livers of mice compared with its parental strain. The most likely explanation is that this mutant enters hepatocytes less eflficiently as it uses only the second pathway and is therefore controlled more easily by the host's immune system. To establish inside a mammalian host, an invasive pathogen must resist the host's innate defense mechanisms. The most common and direct way is to synthesize surface molecules with antiphagocytic activity, for example, polymers of repeated sugar residues (e.g., polysaccharide capsules) or various proteins (8) . An indirect and more subtle way is to invade cells that are not armed to destroy bacteria, such as epithelial or parenchymal cells (8) . These nonprofessional phagocytic cells constitute a sanctuary where bacteria can multiply until a specific immune response develops. L. monocytogenes appears to have evolved the latter strategy.
Using L. monocytogenes as a model, we report the first evidence that the expression of invasion loci allows a pathogen to evade the host's innate defense mechanisms by taking shelter in nonprofessional phagocytes. The timing of this evasion is important. In murine listeriosis, the hepatocytes are invaded early in the course of infection, before neutrophils populate the sites of bacterial implantation (24) . The bacteria can then multiply and propagate in the host tissues by cell-to-cell spreading, preceding phagocytes that are recruited locally. Infection of liver parenchyma by L. monocytogenes can thus be seen as a race between the microorganism and the immune cells. L. monocytogenes must enter the hepatocytes and multiply to numbers capable of overwhelming the host's immune response. Kfipffer cells, neutrophils, and monocytes must hold infection to a level that can be resolved subsequently by a T cell-mediated response.
L. monocytogenes is commonly regarded as a facultative intracellular pathogen whose trademark is to survive and replicate inside host macrophages (9, 38) . The resolution of L. monocHogenes infection is therefore believed to depend on a T cell-mediated activation ofmacrophages, enhancing their microbicidal activity (38) (39) (40) . This study and other reports (13, (24) (25) (26) demonstrate that the principal site of replication ofL. monocytogenes in a living host is the hepatocyte and not the macrophage. By analogy, this may also be true for other facultative intracellular pathogens. It has been shown recently that Salmonella typhimurium and Francisella tularensis also multiply extensively in hepatocytes in mice (41) . An intriguing question is whether the immune system interacts with infected nonphagocytic cells as it does with professional phagocytes to control the bacterial multiplication. Some relevant data have been reported. Listeriainfected mouse hepatocytes are selectively lysed by neutrophils, which are recruited in the infectious foci (13, 24) . It has also been suggested that hepatocytes could be induced to kill Listeria by IFN-~/(42). This fascinating aspect of bacterial immunity is just starting to be explored.
